BREEDLOVE ROBERT CHARLES (Principal Accounting Officer) received a stock award from PHATHOM PHARMACEUTICALS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 2 awards
Filed: 3/3/2026ACC: 0001193125-26-088730
Officer· Principal Accounting Officer
Since Feb 2026
+14.41K
Net shares
Net buyer
$17.3K
Total sold
0
Open market trades
0B · 0S
4
Total transactions
15.79K acquired · 1.38K disposed
Non-Derivative Transactions4
Common Stock
Direct
Shares
+13K
Price / share
—
Trade value
—
% of position
27.6%
2/27/2026
47.07K→60.07K
Common Stock
Direct
Shares
+2.79K
Price / share
—
Trade value
—
% of position
4.6%
2/27/2026
60.07K→62.86K
Common Stock
Direct
Shares
−964.00
Price / share
$12.56
Trade value
$12.11K
% of position
1.5%
2/27/2026
62.86K→61.89K
Common Stock
Direct
Shares
−414.00
Price / share
$12.56
Trade value
$5.20K
% of position
0.7%
2/27/2026
61.89K→61.48K
Total
Net shares
+14.41K
Net value
-$17.31K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 2/27/2026 | A · Award | +13K | — | — | 27.6% | 47.07K | 60.07K |
| Common Stock Direct | 2/27/2026 | A · Award | +2.79K | — | — | 4.6% | 60.07K | 62.86K |
| Common Stock Direct | 2/27/2026 | F · Tax Withholding | −964.00 | $12.56 | $12.11K | 1.5% | 62.86K | 61.89K |
| Common Stock Direct | 2/27/2026 | F · Tax Withholding | −414.00 | $12.56 | $5.20K | 0.7% | 61.89K | 61.48K |
| Total | +14.41K | -$17.31K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)1
Common Stock
IndirectShares owned6.95K
Total
6.95K indirect6.95K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 6.95K | Indirect |
| Total | 6.95K | 6.95K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported